flosequinan

Known as: 7-fluoro-1-methyl-3-methylsulfinyl-4-quinoline, flosequinan [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Although the potent vasodilating effect of flosequinan is well characterised, the positive inotropic action reported is more… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Treatments for heart failure, such as flosequinan, may have opposite effects on survival and quality of life. The Living With… (More)
Is this relevant?
1993
1993
BACKGROUND Angiotensin converting enzyme inhibitors, diuretics, and digoxin are each effective in treating congestive heart… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
1993
1993
OBJECTIVES The aim of this study was to assess the efficacy of flosequinan in chronic heart failure. BACKGROUND Flosequinan is… (More)
Is this relevant?
1992
1992
OBJECTIVES This study was designed to assess the direct effects of flosequinan on myocardial function. BACKGROUND Flosequinan… (More)
Is this relevant?
1991
1991
Flosequinan is an oral arterial and venous vasodilator that is currently under investigation for the treatment of congestive… (More)
Is this relevant?
Review
1991
Review
1991
Flosequinan is a novel quinolone with cardiovascular activity that is likely to be of value in the treatment of both heart… (More)
Is this relevant?
1990
1990
The responses of urine and urinary solute outputs and flows to single doses of 80 mg furosemide, 25 mg hydrochlorothiazide, and… (More)
Is this relevant?
1989
1989
The central and regional hemodynamic effects of flosequinan, a new orally administered vasodilator, were examined in 10 patients… (More)
Is this relevant?
1988
1988
There is no single, simple test with which to evaluate new treatments for heart failure. Various methods need to be used, and a… (More)
  • table I
  • figure 1
  • table I
  • table III
  • figure 2
Is this relevant?